Skip to Main Content

Latest News

De Qué Trata la Inmunoterapia, un Tratamiento Que ha Mostrado Grandes Avances en la Lucha Contra el Cáncer

Este 22 de septiembre el Instituto de Investigación del Cáncer en Estados Unidos llevará a cabo una conferencia virtual en la que abordará varios temas sobre la inmunoterapia y sus beneficios para los pacientes con cáncer. De acuerdo con Kurt Schalper, profesor de la Universidad de Yale, el objetivo de dicha reunión es lograr que la comunidad hispana tenga acceso a información valiosa acerca de dicho tratamiento. | This September 22, the Institute for Cancer Research in the United States will hold a virtual conference in which it will address various topics about immunotherapy and its benefits for cancer patients. According to Kurt Schalper, a professor at Yale University, the objective of this meeting is to ensure that the Hispanic community has access to valuable information about said treatment.

Source: UNIVISION
Read more
  • Cancer Research Institute To Host Second-Annual Spanish-Language Virtual Immunotherapy Patient Summit, Moderated By Ana Patricia Gámez, To Connect The U.S. Hispanic Cancer Community With Information That Can Save Lives

    The Cancer Research Institute (CRI), a nonprofit organization spearheading transformative research to harness the immune system's power to control and potentially cure all cancers, will offer its second annual CRI Virtual Immunotherapy Patient Summit in Spanish on September 22, 2022, 2-5 p.m. ET. This free virtual event, moderated by TV Host and Entrepreneur Ana Patricia Gámez, and presented completely in Spanish, will connect Hispanic cancer patients and caregivers with groundbreaking research updates from leading immunotherapy experts driving scientific breakthroughs and advancements that impact patient care.

    Source: PR Newswire
    Read more
  • Pathology Department Announces 2021 Faculty Promotions

    Chen Liu, MD, PhD, Chair of the Yale Department of Pathology, recently announced the 2021 Faculty Promotions. The 2021 promotion cycle included Natalia Buza, MD, Professor of Pathology, and Themis Kyriakides, PhD, Professor of Pathology, Paul Cohen, MD, Associate Professor of Pathology, Peter Gershkovich, MD, MHA, Associate Professor of Pathology, and Kurt Schalper, MD, PhD, Associate Professor of Pathology.

    Read more
  • Yale Pathology Professor Receives NIH Award for Breakthrough Cancer Research

    The award — granted to just 5% of NIH-funded investigators —ensures that Kurt Schalper’s research will be funded for the next seven years. It supports his groundbreaking work identifying novel pathways for cancer immunotherapy which can be used to optimally select and treat patients with non-small cell lung cancer.

    Source: YaleNews
    Read more
  • Yale enhances its cytometry capabilities

    The methods and equipment used to probe cellular questions are rapidly advancing—including, at Yale, through the addition in 2014 of CyTOF, or Cytometry Time-Of-Flight, and this past June of the CyTOF Imaging Mass Cytometer (IMC), which greatly expands Yale's ability to examine specimens that are analyzed both for clinical diagnosis and for basic research.

    Source: Medicine@Yale
    Read more
  • Yale joins lung cancer Dream Team

    Yale Cancer Center will join a group of prominent cancer research and treatment institutions in a new Stand Up To Cancer (SU2C) – American Cancer Society $20 million Dream Team to combat lung cancer.

    Read more
  • New tool helps identify lung cancer patients who will respond to immune therapies

    A Yale-led team of researchers has developed a new assay, or investigative tool, to measure the anti-tumor immune activity in non-small cell lung cancer tumors that could lead to a more accurate determination of which patients will respond to immune therapy drugs. Findings from the study were published in the Journal of the National Cancer Institute.

    Read more